Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.10.0.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 13, 2018
Aug. 08, 2018
Aug. 03, 2018
Jul. 05, 2018
Mar. 03, 2017
Jul. 30, 2018
Jun. 30, 2018
May 31, 2018
Apr. 30, 2018
Mar. 31, 2018
Jun. 30, 2017
Apr. 19, 2017
Mar. 31, 2017
Dec. 31, 2018
Term                       1 year    
Repayment of loan payable                 $ 500,000          
Interest paid                 175,096          
Loan Payable                 $ 1,000,000          
Maturity date                       Mar. 31, 2020    
Subscription Agreement | Accredited investor                            
Common stock issued, Shares         3,000,000               2,000,000  
Common stock issued, Value         $ 3,000,000                  
Avalon (Shanghai) Healthcare Technology Co., Ltd. | Subscription Agreement | Accredited investor                            
Annual interest                     20.00%   20.00%  
Share price                     $ 1.20   $ 1.20  
Term                     3 years   3 years  
Arbele [Member] | Strategic partnership agreement [Member]                            
Fees paid             $ 100,000              
DOING Biomedical Technology Co., Ltd                            
Related party repayment obligation               $ 1,000,000   $ 200,000        
Subsequent Event [Member]                            
Maturity date     Mar. 31, 2020                      
Subsequent Event [Member] | Accredited investor                            
Common stock issued, Shares   2,000,000                        
Common stock issued, Value   $ 2,000,000                        
Subsequent Event [Member] | Investor                            
Share price $ 2.25                          
Common Shares Sold for Cash, shares 939,450                          
Common Shares Sold for Cash, value $ 2,113,763                          
Subsequent Event [Member] | Board of Directors | Mr. Stilley                            
Option received for acquire of common shares       20,000                   20,000
Exercise price                           $ 2.30
Term                           5 years
Option Vested                           10,000
Quarterly cash payment for service                           7,500
Subsequent Event [Member] | Board of Directors | Mr. Sanders                            
Option received for acquire of common shares           20,000               20,000
Exercise price                           $ 2.80
Term                           5 years
Option Vested                           10,000
Quarterly cash payment for service                           5,000